Cargando…

Identification of new cancer stem cell markers and signaling pathways in HER-2-positive breast cancer by transcriptome sequencing

Human epidermal growth factor receptor (HER)-2-positive breast cancer accounts for ~25% of all breast cancer cases, has a high propensity for relapse, metastasis and drug resistance, and is associated with a poor prognosis. Therefore, it is necessary to develop more effective therapeutic targets for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Lu, Huang, Shangke, An, Gaili, Wang, Guanying, Gu, Shanzhi, Zhao, Xinhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776190/ https://www.ncbi.nlm.nih.gov/pubmed/31545416 http://dx.doi.org/10.3892/ijo.2019.4876

Ejemplares similares

Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor-associated macrophages
por: An, Gaili, et al.
Publicado: (2019)

Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway
por: Zhang, Yujiao, et al.
Publicado: (2018)

Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population
por: Li, Xu, et al.
Publicado: (2016)

Notch1 signaling regulates the epithelial–mesenchymal transition and invasion of breast cancer in a Slug-dependent manner
por: Shao, Shan, et al.
Publicado: (2015)

Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women
por: Wang, Kai, et al.
Publicado: (2019)

Ribosome display and selection of single‐chain variable fragments effectively inhibit growth and progression of microspheres in vitro and in vivo
por: Huang, Shangke, et al.
Publicado: (2018)

The effect of interleukin 10 polymorphisms on breast cancer susceptibility in Han women in Shaanxi Province
por: Li, Miao, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling
por: Luo, Anqi, et al.
Publicado: (2020)

Corrigendum: Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling
por: Luo, Anqi, et al.
Publicado: (2020)

Effects of VEGFR1(+) hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells
por: Meng, Du, et al.
Publicado: (2018)

A pan-cancer analysis of collagen VI family on prognosis, tumor microenvironment, and its potential therapeutic effect
por: Li, Xiang, et al.
Publicado: (2022)

Effects of rat bone marrow-derived mesenchymal stem cells on breast cancer cells with differing hormone receptor status
por: Wang, Ying, et al.
Publicado: (2017)

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
por: Ferrari, Anthony, et al.
Publicado: (2016)

Effects of miR-93 on epithelial-to-mesenchymal transition and vasculogenic mimicry in triple-negative breast cancer cells
por: An, Gaili, et al.
Publicado: (2021)

An Integrated Model of the Transcriptome of HER2-Positive Breast Cancer
por: Kalari, Krishna R., et al.
Publicado: (2013)

Cellular communication promotes mammosphere growth and collective invasion through microtubule-like structures and angiogenesis
por: Huang, Shangke, et al.
Publicado: (2018)

Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer
por: Seo, An Na, et al.
Publicado: (2016)

Plasma‐based microRNA signatures in early diagnosis of breast cancer
por: Li, Xu, et al.
Publicado: (2020)

Human serum albumin-mediated apoptin delivery suppresses breast cancer cell growth in vitro and in vivo
por: Wu, Fang, et al.
Publicado: (2017)

Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling
por: Han, Rui, et al.
Publicado: (2018)

Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer
por: Merry, Callie R., et al.
Publicado: (2016)

Cancer stem cells and HER2 positive breast cancer: The story so far
por: Shah, Deep, et al.
Publicado: (2016)

A yes-associated protein 1- Notch1 receptor positive feedback loop promotes breast cancer lung metastasis by attenuating the bone morphogenetic protein 4-SMAD family member 1/5 signaling
por: Zhao, Lin, et al.
Publicado: (2022)

HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness
por: Pupa, Serenella M., et al.
Publicado: (2021)

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
por: Morsberger, Laura, et al.
Publicado: (2022)

Galectin‐3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2‐positive breast cancer cells
por: Chen, Yuqiu, et al.
Publicado: (2022)

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer
por: Castagnoli, L, et al.
Publicado: (2017)

Immunotherapy for HER-2 positive breast cancer
por: Yang, Tingting, et al.
Publicado: (2023)

Identification of new miRNA biomarkers associated with HER2-positive breast cancers
por: Tashkandi, Hossam, et al.
Publicado: (2015)

Implementation of Next-Generation Sequencing in Saudi Arabia for HER2-Positive Breast Cancer
por: Nassir, Rami, et al.
Publicado: (2022)

HER2/positive and HER2/low in inflammatory breast cancer recurrence
por: Movchan, Oleksii Volodimirovich, et al.
Publicado: (2022)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells
por: Li, Jun, et al.
Publicado: (2017)

TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer
por: Gu, Yayun, et al.
Publicado: (2022)

Clinicopathological Characteristics and Prognosis of Nasopharyngeal Lymphoepithelial Carcinoma: A Population-Based Retrospective Study
por: Xizhi, Liu, et al.
Publicado: (2020)

Modulating cancer stemness provides luminal a breast cancer cells with HER2 positive-like features
por: Mei, Yi, et al.
Publicado: (2020)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
por: He, Licai, et al.
Publicado: (2017)

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
por: Hosonaga, Mari, et al.
Publicado: (2018)

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
por: Stanowicka-Grada, Malwina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d9dqo69geded0kpesh5jf6amko